Anthony Mack
2022
In 2022, Anthony Mack earned a total compensation of $784K as Chief Executive Officer, Chairman at Virpax Pharmaceuticals, a 3% increase compared to previous year.
Compensation breakdown
| Option Awards | $79,000 |
|---|---|
| Salary | $467,000 |
| Stock Awards | $238,000 |
| Total | $784,000 |
Mack received $467K in salary, accounting for 60% of the total pay in 2022.
Mack also received $79K in option awards and $238K in stock awards.
Rankings
In 2022, Anthony Mack's compensation ranked 3,545th out of 5,760 executives tracked by ExecPay. In other words, Mack earned more than 38.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,545 out of 5,760 | 39th |
Division Manufacturing | 2,011 out of 3,136 | 36th |
Major group Chemicals And Allied Products | 961 out of 1,422 | 32nd |
Industry group Drugs | 899 out of 1,323 | 32nd |
Industry Pharmaceutical Preparations | 655 out of 969 | 32nd |
Source: SEC filing on December 7, 2023.
Mack's colleagues
We found two more compensation records of executives who worked with Anthony Mack at Virpax Pharmaceuticals in 2022.